BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15013648)

  • 1. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
    Yoshida M; Miyamae K; Iwashita H; Otani M; Inadome A
    Urology; 2004 Mar; 63(3 Suppl 1):17-23. PubMed ID: 15013648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of bladder function by peripheral nerves: avenues for novel drug targets.
    Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
    Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit.
    Yokota T; Yamaguchi O
    J Urol; 1996 Nov; 156(5):1862-6. PubMed ID: 8863633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic P2X3 heteroreceptors enhance parasympathetic motor drive in isolated porcine detrusor, a reliable model for development of P2X selective blockers for detrusor hyperactivity.
    D'Agostino G; Condino AM; Calvi V; Boschi F; Gioglio L; Barbieri A
    Pharmacol Res; 2012 Jan; 65(1):129-36. PubMed ID: 22041665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch-induced acetylcholine release in female rat bladder.
    Yoshida J; Aikawa K; Yoshimura Y; Shishido K; Yanagida T; Yamaguchi O
    Neurourol Urodyn; 2007; 26(7):1050-5. PubMed ID: 17480029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic agonists and antagonists: effects on the urinary bladder.
    Sellers DJ; Chess-Williams R
    Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2X receptors and their role in female idiopathic detrusor instability.
    O'Reilly BA; Kosaka AH; Knight GF; Chang TK; Ford AP; Rymer JM; Popert R; Burnstock G; McMahon SB
    J Urol; 2002 Jan; 167(1):157-64. PubMed ID: 11743296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder.
    Lai HH; Boone TB; Yang G; Smith CP; Kiss S; Thompson TC; Somogyi GT
    Neurochem Int; 2004 Dec; 45(8):1185-93. PubMed ID: 15380628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of solifenacin on human isolated urinary bladder.
    Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
    Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emptying against outflow obstruction--pharmacological aspects.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1997; 184():77-84. PubMed ID: 9165626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Prejunctional P2x2/3 Heterotrimers by ATP Enhances the Cholinergic Tone in Obstructed Human Urinary Bladders.
    Silva-Ramos M; Silva I; Faria M; Ferreirinha F; Correia-de-Sá P
    J Pharmacol Exp Ther; 2020 Jan; 372(1):63-72. PubMed ID: 31636173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimuscarinic mechanisms and the overactive detrusor: an update.
    Andersson KE
    Eur Urol; 2011 Mar; 59(3):377-86. PubMed ID: 21168951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.
    Kumar V; Chapple CR; Rosario D; Tophill PR; Chess-Williams R
    Eur Urol; 2010 Jun; 57(6):1087-92. PubMed ID: 20022422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: role of purinergic signaling in the pathophysiology of bladder dysfunction.
    Ruggieri MR
    Nat Clin Pract Urol; 2006 Apr; 3(4):206-15. PubMed ID: 16607369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-neuronal cholinergic system in human bladder urothelium.
    Yoshida M; Inadome A; Maeda Y; Satoji Y; Masunaga K; Sugiyama Y; Murakami S
    Urology; 2006 Feb; 67(2):425-30. PubMed ID: 16461116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the urothelium and ATP in mediating detrusor smooth muscle contractility.
    Santoso AG; Sonarno IA; Arsad NA; Liang W
    Urology; 2010 Nov; 76(5):1267.e7-12. PubMed ID: 20869103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of bladder smooth muscle cells to obstruction: signal transduction and the role of mechanosensors.
    Yamaguchi O
    Urology; 2004 Mar; 63(3 Suppl 1):11-6. PubMed ID: 15013647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction.
    Silva I; Ferreirinha F; Magalhães-Cardoso MT; Silva-Ramos M; Correia-de-Sá P
    J Urol; 2015 Oct; 194(4):1146-54. PubMed ID: 26004864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.